Skip to content
777 Sourcing.

Capability

liquid biopsy analysis

Suppliers
2
States & provinces
2
Countries
1

2 liquid biopsy analysis suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

BIOFLUIDICA, INC.

CARY, NC

BioFluidica is a privately held biotechnology and liquid biopsy company that developed the LiquidScan platform, which isolates and analyzes liquid biopsy biomarkers including rare cells, extracellular vesicles (exosomes), and cfDNA on one fully automated platform. LiquidScan combines microfluidics, immunoaffinity chemistries, automation hardware, and workflow optimization. The platform has been clinically tested on nine cancer and prenatal patient samples and is used for research applications. BioFluidica also develops scientific instruments, reagents, a

automation hardwareCTC isolationexosome isolationfetal cell isolationimmunoaffinity chemistriesmicrofluidicsrare cell isolation

Compiled from public sources

CANSERA INC

LOS ANGELES, CA

Cansera is an AI-driven biotechnology startup focused on unlocking digital biomarkers from routine blood tests to transform cancer care. It developed a cloud-based software platform using advanced machine learning to analyze entire blood samples and detect rare tumor-related cells without preselecting markers, replacing labor-intensive manual review with reproducible AI.

cloud-based data processingdigital microscopy & analysismachine learningrare-cell detection

Compiled from public sources

Related capabilities

Other processes offered by the shops that list liquid biopsy analysis.

Browse all capabilities